PTEN and melanoma: Interestingly, in this subset of melanoma cell lines, treatment with MEK inhibitor did not result in a down-regulation of S6 ribosome protein phosphorylation, suggesting MEK-ERK signaling may not regulate mTORC1 functions in this context, possibly due to a PTEN dominant regulation on the AKT pathway.